More Stories

More Stories

June 3, 2018

“We are at a turning point in the history of cancer,” said Scott Gottlieb, MD, commissioner of the U.S. Food and Drug Administration (FDA), addressing the crowded room of ASCO attendees during the Opening Session on June 2.

Read more

June 2, 2018

With recent approvals of pembrolizumab and nivolumab for the treatment of refractory deficient mismatch repair (dMMR) metastatic colorectal cancer (CRC), immunotherapy has made its way into the field of gastrointestinal oncology.

Read more

June 2, 2018

Therapies that target the protein HER2 have changed the landscape of cancer treatment, improving survival in advanced HER2-positive breast and gastric cancers.

Read more

June 2, 2018

Te bb2121 chimeric antigen receptor (CAR) T-cell therapy engineered to target B-cell maturation antigen (BCMA) holds great promise for the treatment of multiple myeloma (MM).

Read more

June 2, 2018

The combination of ibrutinib and rituximab significantly improved progression-free survival (PFS) and response rates compared to placebo plus rituximab in patients with Waldenström’s macroglobulinemia (WM).

Read more

June 2, 2018

Rearranged during transfection (RET) is an oncogene activated by RET fusions or RET mutations. RET fusions are associated with 2% of non–small cell lung cancers (NSCLCs), 10%-20% of papillary and other thyroid cancers, and smaller proportions of other cancers.

Read more

June 2, 2018

Stress from a cancer diagnosis and anticipation of treatment is ubiquitous among patients.

Read more

June 2, 2018

The use of adjuvant chemotherapy to reduce the recurrence of breast cancer has been linked to significant improvements in mortality and morbidity, including disease-free survival (DFS) and overall survival (OS), in women with early-stage disease.

Read more

June 2, 2018

Michael G. Martin, MD, a medical oncologist of West Cancer Center, has attended the ASCO Annual Meeting for more than 10 years.

Read more

June 2, 2018

During his 25-year academic career as a medical oncologist and scientist, Gregory P. Kalemkerian, MD, has mentored and taught countless trainees.

Read more

June 2, 2018

Gideon Michael Blumenthal, MD, a medical oncologist, has been named the recipient of ASCO’s 2018 Public Service Award.

Read more

June 2, 2018

Burnout among oncologists is a pressing issue that directly affects physicians’ ability to provide the highest quality of patient care.

Read more

June 2, 2018

Obesity is a major public health issue in the United States, and the rates have risen dramatically since 1990.

Read more

June 2, 2018

Rejin Kebudi, MD, a professor of pediatrics and a pediatric hematologist-oncologist with Istanbul University, Turkey, is the 2018 recipient of the International Women Who Conquer Cancer Mentorship Award.

Read more

June 2, 2018

The ASCO Daily News spoke with ASCO members about their experience using ASCO University® resources in their practices.

Read more

June 2, 2018

Ralph R. Weichselbaum, MD, the Daniel K. Ludwig  has been named the 2018 David A. Karnofsky Memorial Award and Lecture recipient for his career-long contributions to the field of radiation oncology.

Read more

June 1, 2018

In November, the U.S. Food and Drug Administration announced its approval of the first breakthrough-designated, next-generation sequencing (NGS)-based diagnostic test, the FoundationOne CDx.

Read more

June 1, 2018

Cancer care has a considerable economic impact worldwide. In 2015, the Agency for Healthcare Research and Quality (AHRQ) estimated that the direct medical costs (total of all health care costs) for cancer in the United States were $80.2 billion.

Read more

June 1, 2018

We hear from patients that they are told by friends: “Educate yourself, have hope and courage, get support.”

Read more
June 1, 2018

Saturday InBriefs: Scientific Highlights from ASCO18.

Read more